Gender disparities in pneumonia: Why men face higher risks
Recent research has unveiled a stark difference in the way pneumonia impacts men and women, highlighting that men are more vulnerable to severe cases and ... Read More
Wockhardt makes breakthrough in pneumonia treatment with Nafithromycin WCK 4873
Wockhardt is proud to announce the successful completion of its pivotal Phase 3 pneumonia study involving the macrolide antibiotic Nafithromycin WCK 4873. This significant achievement ... Read More
Health crisis in China: Surge in respiratory illnesses triggers emergency response
China is grappling with a staggering surge in respiratory illnesses, prompting the National Health Commission to call for an urgent increase in the number of ... Read More
Panic grips China: Unprecedented spike in child respiratory cases – What’s hidden?
In an alarming development, China reports a significant surge in respiratory illnesses among children in the north, causing international concern. The World Health Organization (WHO), ... Read More
Is a new pandemic emerging in China? Alarming pneumonia outbreak in schools!
China is facing a new health emergency as a mysterious pneumonia outbreak, eerily reminiscent of the early COVID-19 crisis, sweeps through schools. Hospitals in Beijing ... Read More
GSK to acquire vaccine developer Affinivax in deal worth up to $3.3bn
GlaxoSmithKline (GSK) has agreed to acquire Affinivax, a Boston-based clinical-stage vaccine developer, in a deal worth up to $3.3 billion. The consideration includes an upfront ... Read More
RedHill Biopharma expands U.S. partnerships for opaganib manufacturing amid COVID-19 fight
Israeli biopharma company RedHill Biopharma has significantly advanced its efforts to combat COVID-19 by forging strategic partnerships with two U.S.-based manufacturers. These collaborations aim to ... Read More
Humanigen announces positive interim results for lenzilumab in COVID-19 phase 3 trial
Humanigen, a U.S.-based biopharmaceutical company, has revealed promising interim data from its phase 3 clinical trial of lenzilumab, a monoclonal antibody designed to treat COVID-19. ... Read More
Gilead Sciences announces Veklury EU approval for COVID-19 treatment
Veklury EU approval : Gilead Sciences said that Veklury (remdesivir) has been given conditional marketing authorization from the European Commission as a treatment for SARS-CoV-2 ... Read More
Gilead Covid-19 drug candidate remdesivir delivers desired results in phase 3 trial
Remdesivir clinical trial results : Gilead Sciences said that the phase 3 SIMPLE trial, which has been evaluating the Covid-19 drug candidate remdesivir for the ... Read More